Cytokine Storm and Its Role in the Severity of Respiratory Viral Diseases
DOI:
https://doi.org/10.46966/msjar.v6i3.272Keywords:
Respiratory Viral Disease, Cytokine Strom, IL-6, TNF-α, IL-1βAbstract
Background: Cytokine storms, indicating an exaggerated immune response, are key to the virulence of respiratory viral infection. Our study contrasts cytokine storm profiles in parainfluenza, influenza, and rhinovirus infection and investigates the impact of age and gender. Methods: 350 samples were collected, of which 300 were patient samples and 50 were control samples. They were diagnosed through VIDS technology to detect viruses, and ELISA was used for the quantification of cytokines (IL-6, TNF-α, IL-1). Statistical tests utilized were t-tests and analysis of variance (ANOVA) in order to compare group differences. Results: The results indicated that influenza virus induces higher cytokine levels among elderly individuals (over 65 years of age), followed by parainfluenza and rhinovirus. Females exhibited a stronger immune response, which is due to hormonal and genetic causes. Sex and age significantly affect the intensity of the cytokine storm because immune aging and the inflammatory response of elderly individuals lead to an overreaction of the immune system. Conclusion: Our conclusions offer several trends of cytokine storms in respiratory viruses, with influenza being the most lethal. Age and gender are also significant demographic predictors, providing valuable insights for targeted treatment.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Zainab Mohammed Madfoon
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
